| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.5B | $1.4B | $1.3B | $1.1B | $0.9B | $0.9B | $0.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.2B | $1.9B | $2.0B | $2.2B | $1.3B | $0.8B | $0.3B | $0.3B |
| EPS (Basic) | $1.41 | $1.24 | $1.26 | $1.47 | $0.91 | $0.71 | $0.29 | $0.30 |
| EPS (Diluted) | $1.39 | $1.22 | $1.24 | $1.45 | $0.90 | $0.69 | $0.28 | $0.29 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $225.1B | $204.2B | $189.4B | $182.9B | $174.1B | $123.0B | $109.0B | $108.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $2.7B |
| Total Liabilities | $200.7B | $184.4B | $170.0B | $165.1B | $154.7B | $110.0B | $97.2B | $97.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $24.3B | $19.7B | $19.4B | $17.7B | $19.3B | $13.0B | $11.8B | $11.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $1.8B | $2.7B | $4.0B | $2.1B | $1.3B | $1.6B | $1.7B |
| Investing Cash Flow | $-6.3B | $-12.1B | $-3.0B | $-11.6B | $-4.0B | $-8.6B | $-1.9B | $-3.7B |
| Capital Expenditures | $0.3B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $4.5B | $13.0B | $3.8B | $8.8B | $0.8B | $12.7B | $-1.2B | $3.1B |